Impact of Deutetrabenazine on Functional Speech and Gait Dynamics in Huntington Disease
Phase 2/3 study testing deutetrabenazine in Huntington's disease.
Active, not recruitingPhase 2 / Phase 3DrugClinicalTrials.govTreatment trial
Recruiting in: Nashville, United States
Sponsor: Vanderbilt University Medical Center
Preparing a short plain-English summary.